CIK 0001583648
- Non-accelerated filer
- Smaller reporting company
PALVELLA THERAPEUTICS, INC.
Sign in to watch- Ticker
- PVLA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 300784346
- Phone
- +1 484-253-1461
- Business address
- 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,071,070
- in 6 filings, $11.0M under 10b5-1 plans
Net −$11,071,070. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-26 | Reine Allan Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +162,500 | 162,500 | ||
| 2018-02-20 | Reine Allan Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +53,833 | 53,833 | ||
| 2018-02-20 | Reine Allan Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +50,000 | 50,000 | ||
| 2017-08-17 | Reine Allan | Purchase | +20,000 | $4.89 | $98K | 65,000 |
| 2017-08-16 | Reine Allan | Purchase | +45,000 | $4.79 | $216K | 45,000 |
| 2017-08-09 | Reine Allan | Grant or award · Common Stock | +450,000 | 450,000 |
Page 1 of 1 · 6 trades